Aug 14, 2025, 09:23 AM by

Aug 14, 2025, 01:00 AM by User Not Found

Bio-IT World | San Francisco biotech Openwater is pioneering a multi-purpose platform approach to medical device development, combining infrared light and low-intensity focused ultrasound technologies to create what CEO Aaron Timm describes as the "smartphone" of medical devices.

Aug 13, 2025, 01:00 AM by User Not Found

Bio-IT World | Virginia Commonwealth University researchers have developed an artificial intelligence platform that could dramatically accelerate biotech research by solving one of the field's most computationally intensive challenges—rapidly identifying and analyzing distinct cell types in complex biological tissues.

Aug 12, 2025, 09:55 AM by

Powered by the industry’s largest set of digitized protocols and operational data, Braid enables smarter trial design and greater operational efficiency

Aug 12, 2025, 09:55 AM by

With goal of delivering reliable AI solutions for life sciences companies, CapeStart continues to build out GenAI expertise, services, and the MadeAi™ platform

Aug 12, 2025, 01:00 AM by User Not Found

Bio-IT World | The pharma industry excels at collaborating with startup companies and scaling up the production of drugs and biologics, but they may be missing the big-picture perspective of the U.S. government as well as some of the cutting-edge research happening within academia. It’s a problematic norm that needs addressing if artificial intelligence (AI) is to benefit drug discovery and diagnostics as well as healthcare delivery in terms of safety, equity, and effectiveness.

Aug 11, 2025, 09:09 AM by

Memorial Healthcare System Deploys Population Health Technology to Drive Medication Adherence

Aug 8, 2025, 11:50 AM by

Aug 8, 2025, 11:50 AM by

Aug 7, 2025, 09:00 AM by

Accessible, patient-focused & CMS-required medication instructions save nurses time during inpatient care, while improving HCAHPS scores for patient satisfaction

Aug 7, 2025, 09:00 AM by

LabConnect has officially completed the global deployment of LIMSConnect, its internal name for the enterprise-wide implementation of Sapio LIMS, across more than 30 locations on six continents. Built on Sapio’s configurable, AI-enabled lab informatics platform, LIMSConnect unifies complex sample workflows, improves data integrity, and enables scalable innovation across LabConnect’s central laboratory network.

Aug 7, 2025, 09:00 AM by

Biocair, an established global leader in life science logistics, announced the further expansion of its operations in the APAC region with the opening of a new office in Shanghai, China.

Aug 7, 2025, 01:00 AM by User Not Found

Bio-IT World | Russia plans to significantly expand its national database of genetic information by 2030 according to a recent decree approved by the Russian government. As part of the plans, the volume of the already existing database will be increased by 35 times and reach 35 petabytes by 2030.

Aug 6, 2025, 09:11 AM by

VieCure adds Summit Cancer Centers to community oncology care network.

Aug 6, 2025, 09:11 AM by

Supreme Group Acquires Pivot Design, Marking a Significant Expansion in Pharma and Rare Disease

Aug 6, 2025, 09:11 AM by

Aug 6, 2025, 09:11 AM by

Alfa Chemistry has launched a new portfolio of food surfactants designed to improve stability, texture, and processing efficiency in modern food manufacturing, supporting clean-label and plant-based formulation trends.

Aug 6, 2025, 01:00 AM by User Not Found

Bio-IT World | The Alzheimer's Association International Conference was held last week in Toronto and researchers and companies gathered to present their progress in the fight to diagnose and treat Alzheimer’s disease. Among the timely new developments: new products from Quanterix; pre-clinical data from AltPep, OncoC4, and NKGen Biotech; pipeline updates from Eisai, Biogen, and Roche; and more.

Aug 5, 2025, 09:17 AM by

MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced a research collaboration with Syntekabio, Inc., a leading artificial intelligence (AI)-driven drug discovery company, to identify additional disease targets and optimize the therapeutic profile of DA-1241, MetaVia’s novel oral G-Protein-Coupled Receptor 119 (GPR119) agonist.

Aug 5, 2025, 09:17 AM by

• Investment in premises on Cambridge Technopark reflects significant milestone in the Company’s growth • Relocation increases logistics and R&D capacity, enabling faster customization and turnaround, strengthening order fulfilment to better support customers in their research and development efforts